Palouse Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Buy |
4,573
+1,761
| +63% | +$714K | 1.22% | 39 |
|
|
2025
Q1 | $1.4M | Buy |
2,812
+10
| +0.4% | +$4.98K | 0.95% | 45 |
|
|
2024
Q4 | $1.46M | Buy |
2,802
+1,166
| +71% | +$607K | 0.97% | 46 |
|
|
2024
Q3 | $1.01M | Sell |
1,636
-809
| -33% | -$500K | 0.64% | 56 |
|
|
2024
Q2 | $1.35M | Sell |
2,445
-74
| -3% | -$40.9K | 0.91% | 46 |
|
|
2024
Q1 | $1.46M | Sell |
2,519
-109
| -4% | -$63.4K | 0.97% | 46 |
|
|
2023
Q4 | $1.39M | Sell |
2,628
-3
| -0.1% | -$1.59K | 0.99% | 47 |
|
|
2023
Q3 | $1.33M | Buy |
2,631
+381
| +17% | +$193K | 0.99% | 47 |
|
|
2023
Q2 | $1.17M | Sell |
2,250
-142
| -6% | -$74.1K | 0.82% | 52 |
|
|
2023
Q1 | $1.38M | Buy |
2,392
+368
| +18% | +$212K | 0.93% | 48 |
|
|
2022
Q4 | $76.1M | Sell |
2,024
-111
| -5% | -$4.17M | 5.26% | 4 |
|
|
2022
Q3 | $1.08M | Sell |
2,135
-38
| -2% | -$19.3K | 0.62% | 60 |
|
|
2022
Q2 | $1.18M | Sell |
2,173
-50
| -2% | -$27.2K | 0.59% | 60 |
|
|
2022
Q1 | $1.31M | Sell |
2,223
-43
| -2% | -$25.4K | 0.58% | 61 |
|
|
2021
Q4 | $1.51M | Sell |
2,266
-1,595
| -41% | -$1.06M | 0.65% | 58 |
|
|
2021
Q3 | $2.21M | Sell |
3,861
-82
| -2% | -$46.9K | 0.98% | 46 |
|
|
2021
Q2 | $1.99M | Buy |
3,943
+28
| +0.7% | +$14.1K | 0.87% | 53 |
|
|
2021
Q1 | $1.79M | Buy |
+3,915
| New | +$1.79M | 0.79% | 50 |
|